When and how to use predictive biomarkers for corticosteroid treatment of septic shock

by James A. Russell
Published 2018-11-01

Sepsis breakthroughs in 2014 [v1; ref status: indexed, http://f1000r.es/5ft]

by James A. Russell, Keith R. Walley
Published 2015-05-01

Vasopressin versus norepinephrine in septic shock: a propensity score matched efficiency retrospective cohort study in the VASST coordinating center hospital

by James A. Russell, Hugh Wellman, Keith R. Walley
Published 2018-11-01

Education and the Attribution of Emotion to Facial Expressions

by Nicole M Trauffer, Sherri C Widen, James A Russell
Published 2013-09-01

Education and the Attribution of Emotion to Facial Expressions

by Nicole M Trauffer, Sherri C Widen, James A Russell
Published 2013-09-01

Significance of lactate clearance in septic shock patients with high bilirubin levels

by Nozomi Takahashi, Taka-aki Nakada, Keith R. Walley, James A. Russell
Published 2021-03-01

Study protocol for a multicentre, prospective cohort study of the association of angiotensin II type 1 receptor blockers on outcomes of coronavirus infection

by James A. Russell, Arthur Slutsky, Dave Sweet, David M Patrick, Matthew Cheng
Published 2020-12-01

Cytokines and signaling molecules predict clinical outcomes in sepsis.

by Christopher D Fjell, Simone Thair, Joseph L Hsu, Keith R Walley, James A Russell, John Boyd
Published 2013-01-01

Lipopolysaccharide Is Cleared from the Circulation by Hepatocytes via the Low Density Lipoprotein Receptor.

by Elena Topchiy, Mihai Cirstea, HyeJin Julia Kong, John H Boyd, Yingjin Wang, James A Russell, Keith R Walley
Published 2016-01-01

Correction: Lipopolysaccharide Is Cleared from the Circulation by Hepatocytes via the Low Density Lipoprotein Receptor.

by Elena Topchiy, Mihai Cirstea, HyeJin Julia Kong, John H Boyd, Yingjin Wang, James A Russell, Keith R Walley
Published 2016-01-01

Survival benefit of a low ratio of visceral to subcutaneous adipose tissue depends on LDL clearance versus production in sepsis

by Joseph G. H. Lee, Kelly R. Genga, Chawika Pisitsak, John H. Boyd, Alex K. K. Leung, James A. Russell, Keith R. Walley
Published 2018-03-01

Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients

by James A. Russell, Jean-Louis Vincent, Anne Louise Kjølbye, Håkan Olsson, Allan Blemings, Herbert Spapen, Peder Carl, Pierre-Francois Laterre, Lars Grundemar
Published 2017-08-01

Mean arterial pressure and mortality in patients with distributive shock: a retrospective analysis of the MIMIC-III database

by Jean-Louis Vincent, Nathan D. Nielsen, Nathan I. Shapiro, Margaret E. Gerbasi, Aaron Grossman, Robin Doroff, Feng Zeng, Paul J. Young, James A. Russell
Published 2018-11-01

Impact of PCSK9 loss-of-function genotype on 1-year mortality and recurrent infection in sepsis survivorsResearch in context

by Kelly Roveran Genga, Cody Lo, Mihai S. Cirstea, Fernando Sergio Leitao Filho, Keith R. Walley, James A. Russell, Adam Linder, Gordon A. Francis, John H. Boyd
Published 2018-12-01

An Endotoxin Tolerance Signature Predicts Sepsis and Organ Dysfunction at Initial Clinical Presentation

by Olga M. Pena, David G. Hancock, Ngan H. Lyle, Adam Linder, James A. Russell, Jianguo Xia, Christopher D. Fjell, John H. Boyd, Robert E.W. Hancock
Published 2014-11-01

Pharmacogenomic biomarkers do not predict response to drotrecogin alfa in patients with severe sepsis

by Djillali Annane, Jean-Paul Mira, Lorraine B. Ware, Anthony C. Gordon, Charles J. Hinds, David C. Christiani, Jonathan Sevransky, Kathleen Barnes, Timothy G. Buchman, Patrick J. Heagerty, Robert Balshaw, Nadia Lesnikova, Karen de Nobrega, Hugh F. Wellman, Mauricio Neira, Alexandra D. J. Mancini, Keith R. Walley, James A. Russell
Published 2018-01-01

Erratum to: Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine

by Sangeeta Mehta, John Granton, Anthony C. Gordon, Deborah J. Cook, Stephen Lapinsky, Gary Newton, Kris Bandayrel, Anjuli Little, Chuin Siau, Dieter Ayers, Joel Singer, Terry C. K. Lee, Keith R. Walley, Michelle Storms, D. James Cooper, Cheryl L. Holmes, Paul Hebert, Jeffrey Presneill, James A. Russell, for the Vasopressin and Septic Shock Trial (VASST) Investigators
Published 2017-05-01

Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in COVID-19: Meta-analysis/Meta-regression Adjusted for Confounding Factors

by Terry Lee, PhD, Alessandro Cau, BSc, Matthew Pellan Cheng, MD, Adeera Levin, MD, Todd C. Lee, MD, Donald C. Vinh, MD, Francois Lamontagne, MD, Joel Singer, PhD, Keith R. Walley, MD, Srinivas Murthy, MD, David Patrick, MD, Oleksa G. Rewa, MD, Brent W. Winston, MD, John Marshall, MD, John Boyd, MD, Karen Tran, MD, Andre C. Kalil, MD, Russell Mcculoh, MD, Robert Fowler, MD, James M. Luther, MD, James A. Russell, MD
Published 2021-07-01